GPX3 and ductal breast carcinoma in situ: Transwell invasion assays showed that knockdown of PTPN12, YTHDC2, and MAPKAPK3, as well as overexpression of GPX3, RASA3, and TSPAN4, significantly inhibited the invasive capacity of DCIS cells (Figure 11A,C,D).